Bulletin du Cancer
Volume 84, issue 4, Avril 1997
Volume 84, issue 4, Avril 1997
Editorial
Hello Dolly, ewe’re welcome
(p.341-2)
Philippe Jeanteur
Articles originaux
Effect of quinine on the multidrug resistance and intracellular distribution
of THP-DOX in LR73 tumor cells: comparative study with verapamil
and S9788 by confocal laser microspectrofluorometry
(p.343-9)
Rajae Belhoussine, Hamid Morjani, Michel Manfait
Subcutaneous administration of interleukin-2 in treatment of patients with
metastatic renal cell carcinoma. Three-year results of SCAPP I trial
(p.351-6)
Jean-Marc Tourani, Christine Jaillon-Abraham, Virginie Lucas, Yves Chrétien, Didier Mayeur, Marc Di Palma, Catherine Boaziz, Philippe Grise, Charles Varette, Jean-Marc Pavlovitch, Dominique Larregain, Evelyne Ecstein, Michel Untereiner, Jean-Marie Andrieu
Split-course concomitant radiochemotherapy plus surgery versus surgery alone
for squamous cell carcinomas of the esophagus. A non-randomized retrospective study of 184 patients
(p.357-67)
Jean-Pierre Malhaire, Patrick Lozac’h, Hélène Simon, Jean-Paul Labat, Philippe Topart, Brigitte Lucas, Jean-Philippe Metges, Bruno Lamezec
Evaluation of long-term results of a modified VAB-6 chemotherapy regimen
in a cohort of good-risk metastatic non seminomatous germ-cell tumors
(p.368-72)
Stéphane Culine, Isabelle Philippot, Fadi Farhat, Christine Théodore, Marie-Josée Terrier-Lacombe, Jean-Pierre Droz
Cancer of the uterine cervix in young women. A retrospective analysis of 337 cases
(p.373-8)
Abdelkader Acharki, Souha Sahraoui, Abdellatif Benider, Nezha Tawfiq, Hassan Jouhadi, Najib Bouras, Redouane Samlali, Abdelouahed Kahlain
Burkitt’s lymphoma in Cameroonian children: epidemiological
and clinico-anatomical profile
(p.379-83)
Pierre Doumbé, André Mbakop, Marie-Thérèse Essomba Mboumi, Marie-Thérèse Obama, Innocent Kago, Joseph Gonsu, Michel Santiago, Ekoe Tetanye
Synthèses
Non P-glycoprotein novel proteins involved in human cancer multidrug resistance
(p.385-90)
Loris G. Baggetto
Tumoral vascularization: physiopathology and therapeutic prospects
(p.391-5)
Nathalie Ortéga, Sylvie Sordello, Jean Plouët
Receptors for factors of the VEGF family
(p.397-403)
Emmanuel Fournier, Daniel Birnbaum, Jean-Paul Borg
Concomitant radio-chemotherapy in invasive bladder tumors
(p.405-11)
Nicolas Mottet, Mario Di Palma, Christophe Avances, Pierre Costa, Alain Jardin, Jean-Louis Misset
Therapeutic options and innovative approaches in inoperable locally advanced non small-cell lung cancer (stage IIIB)
(p.413-9)
Axel Le Cesne, Rodrigo Arriagada, Dominique Grunenwald, Pierre Baldeyrou, Philippe Girard, Jean-Jacques Bretel, Thierry Le Chevalier
Etudes de cas
Non Hodgkin’s malignant lymphoma of the uterine cervix. A case report
(p.421-2)
El Abbes El Ghazi, Hamid Mansouri, Mhamed Melhouf, Hassan Errihani, Aziz Mansouri, Nourredine Benjaafar, Mohamadine Alhilal, Brahim Khalil El Gueddari
Malignant melanoma of the ano-rectal region: case report and review of the literature
(p.423-6)
Mariano Malaguarnera, Giovanni Pistone, Lino Succi, Tindaro Pontillo, Antonina Laurino, Domenico Russello
Point sur…
The tribulations of the tumor suppressor gene p16/MTS1/CDKN2: a continuing saga
(p.427-30)
Christian-Jacques Larsen
Gene therapy for primary liver cancer: hopes and realities
(p.431-4)
Nicolas Ferry
Soon, a new interferon for melanoma treatment... Handle with care!
(p.435-7)
Sylvie Négrier
Compte rendu de congrès
Management of malignant tumor spread: from biology to therapy
(p.439-42)
Susy Scholl, Philippe Beuzeboc, Pierre Pouillart
Which function(s) for trefoil peptides?
(p.443-6)
Marie-Christine Rio
New potential inhibitors of tumor angiogenesis
(p.447-50)
Virginie Mattot, Bernard Vandenbunder
New therapeutic approaches in acute myelogenous leukemia (AML)
and chronic myelogenous leukemia (CML)
(p.451-2)
Jean-Pierre Marie